Spring Research Update Meeting 2022 – recorded to watch again
Theme: Why diabetes drugs might be an important potential line of treatment for Parkinson’s
Recorded at an in-person event.
The association between Type 2 diabetes and Parkinson’s risk and severity – Dr Alastair Noyce, Queen Mary University of London
Liraglutide in the treatment of Parkinson’s – Prof Michele Tagliati, Cedars Sinai
Exenatide for Parkinson’s – what’s next? – Dr Dilan Athauda, University College London
Our monthly e-newsletter
Stay informed about upcoming research update meetings and our latest research news
How helpful was this content?
/ 5. Vote count:
We are sorry that this content was not useful for you
Let us improve this content
Can you tell us how we can improve this content?